Molecular and Functional imaging guidelines for clinical trials, from sponsored workshops and other sources.
Information regarding Response Evaluation Criteria In Solid Tumors (RECIST) for imaging clinical trials.
Screening and imaging interventional trials are sponsored by ACRIN and other agencies.
ACRIN is funded to improve the quality and utility of imaging in cancer research and cancer care through expert, multi-institutional clinical evaluation of discoveries and technological innovations relevant to imaging science as applied in clinical oncology.
Within the CIP program, the current R21 mechanism provides potential funding for small, single institution feasibility trials. The current announcement is titled In Vivo Cancer Imaging Exploratory/Developmental Grants.
The Cancer Imaging Program is sponsoring limited Phase I/II trials for new imaging agents and methods.
Several clinical trials were funded with ARRA funds.
Often imaging is used as a surrogate marker for therapeutic trials of various cancer drugs. Specific information about this process is currently available through the Cancer Therapy Evaluation Program. CIP is currently assisting CTEP in drafting more specific guidelines for the incorporation of imaging into therapeutic clinical trials.
The NCI Intramural Center for Cancer Research Molecular Imaging Program is a multidisciplinary group consisting of imaging scientists, chemists, physicists, engineers and molecular biologists. There is a strong collaboration with Dr. Martin Brechbiel's Radioimmune and Inorganic Chemistry Section of the Radiation Oncology Branch, NCI. The focus of the MIP is on the clinical translation of targeted imaging agents for cancer imaging.
Provides imaging resources for quality patient care, provides training, and performs basic and clinical research sponsored by the NIH Institutes and the Clinical Center.
As the research hospital for the National Institutes of Health, the Clinical Center supports clinical research done by all the other Institutes and Centers, as well as conducts research done by its own staff.
Search the world's most comprehensive cancer clinical trials database. It includes approximately 2,000 abstracts of trials that are open/active and approved for patient accrual (and 13,000 abstracts of closed clinical trials), including trials for cancer treatment, genetics, diagnosis, supportive care, screening, and prevention.
Provides regularly updated information about federally and privately supported clinical research in human volunteers.